最新更新 :
01/07/2022
薬剤の安定性と配合適合性(配合変化/配合禁忌確認)
Stabilisにようこそ。季刊誌ニュースレターをご希望の方はこちらの欄にe-mailアドレスを入力して下さい。 サインアップ

質問やコメントがございましたらメール下さい: infostab@stabilis.org
データベース  
引用文献 : 2715
化合物 : 840
薬理学分類 : 46
溶液の安定性 : 6130
混合時の安定性 : 1213
互換性 : 12078
商品名 : 4607
ニュース - 化合物  
細胞増殖抑制薬 経口液 Ruxolitinib 28/06/2022
様々なもの 注射薬 Atosiban 02/06/2022
様々なもの 経口液 Epigallocatechin gallate 02/06/2022
血糖降下薬 経口液 Sitagliptine phosphate 02/06/2022
様々なもの カプセル Fludrocortisone acetate 05/05/2022
抗認知症 経口液 Pimavanserin 05/05/2022
細胞増殖抑制薬 経口液 Imatinib 03/05/2022
細胞増殖抑制薬 軟膏薬 Erlotinib 03/05/2022
抗真菌薬 軟膏薬 Voriconazole 03/05/2022
電解質 注射薬 Magnesium chloride 14/03/2022
免疫抑制薬 注射薬 Adalimumab 06/03/2022
ホルモン薬 軟膏薬 Gestrinone 04/03/2022
抗炎症薬 軟膏薬 Nimesulide 04/03/2022
抗炎症薬 軟膏薬 Piroxicam 04/03/2022
様々なもの 経口液 Quetiapine fumarate 24/02/2022
抗炎症薬 紙袋 Hydrocortisone 24/02/2022
降圧薬 紙袋 Clonidine hydrochloride 24/02/2022
鎮痛薬 軟膏薬 Morphine hydrochloride 24/02/2022
抗菌薬 経口液 Co-trimoxazole 07/12/2021
細胞増殖抑制薬 注射薬 Isatuximab 01/12/2021
ニュース - 引用文献  
データ入力
4692 Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. The Scientific World Journal 10/06/2022
4686 Pertuzumab (Perjeta®) - Summary of Product Characteristics. Roche Products Ltd. 24/05/2022
4683 Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days J Pharm Pract and Res 05/05/2022
4681 An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Hosp Pharm 03/05/2022
4679 Stability of extemporaneously prepared sitagliptin phosphate solution. PlosOne 12/04/2022
4676 Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days. EAHP Congress Vienna 05/04/2022
4677 Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags. EAHP Congress Vienna 05/04/2022
4675 Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations. Pharmaceuticals 18/03/2022
4673 Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Pharmaceutics 16/03/2022
4670 Stability and Formulation of Erlotinib in Skin Creams. Molecules 09/03/2022
4671 Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 09/03/2022
4669 Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration. Neuromodulation 03/03/2022
4666 Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron. J Anal Sci Tech 28/02/2022
4667 Stability of Hydromorphone Hydrochloride and Morphine under Different Clinical Infusion Conditions. Int J Pharm Pharm Sci 28/02/2022
4665 LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021 Sanofi Aventis 15/02/2022
4661 Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization J Pharm Biomed Anal 05/02/2022
4655 Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Am J Health-Syst Pharm 25/01/2022
4653 Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. EJHP 24/01/2022
4654 Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 24/01/2022
4652 Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals 22/01/2022
4651 Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 18/01/2022
4650 Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 12/01/2022
4649 Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. GaBI Journal 29/12/2021
4648 Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method. PlosOne 16/12/2021
4646 Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). Int J Pharm Compound 24/11/2021
4645 Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC Antimicrob Resist 17/11/2021
4643 Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. EJHP 15/11/2021
4640 Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Hosp Pharm 08/11/2021
4641 Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Eur J Pharm Sci 08/11/2021
4642 Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 08/11/2021

  Mentions Légales